跳转到主要内容
The George Institute for Global HealthThe George Institute for Global Health
Covid-19 Covid 19 Covid 19
捐

Social links India

  • Facebook
  • Twitter
  • YouTube
The George Institute for Global Health
  • 关于我们
    • 我们的使命和价值观
    • 我们的策略
    • 我们的历史
    • 我们的研究特色
    • 我们的团队
    • Board Of Directors
    • 研究、影响和策略全球咨询委员会
    • 乔治健康
    • 年度报告
    • 财务报表
    • Our Key Policies
  • 我们的工作
    • 我们的关注点
    • 更好的治疗
    • 更好的护理
    • 促进更健康的社会
    • 现行项目
    • Projects by Our Affiliates
    • 过往项目
    • 出版物
  • 新闻与事记
    • 媒体发布
    • 机构动态
    • 新闻报道
    • Media Enquiries
    • 活动
    • 过去的活动
    • 博客/人物
    • 电子新闻简报
    • 视频
    • Podcasts
  • 我们的成绩
    • Reports And Recommendations
    • Case Studies And Examples
    • Advocacy And Thought Leadership
    • 创新型社会企业
  • 职业和学习
    • 职在乔治
    • 研究培训项目
    • 工作机会
  • 联系我们
  • Get involved
      • Building Back Better After COVID-19: The Research Agenda
      • Reclaiming Comprehensive Public Health: A Call to Action
      • Universal Health Coverage: A Call To Action
      • Donate
    • Donate
    1. 首页

    Professor Vlado Perkovic

    Australia


     

    拓展阅读

    • New breakthrough treatment for kidney disease offers hope for hundreds of millions of people with diabetes worldwide

      15/04/2019

      credence
    • Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial (with subtitles)

    • 1.4 million people die every year in India because they cannot afford dialysis

    • Steroid treatment may lead to high risks for kidney disease associated with excess protein in urine

      02/08/2017

    • World’s first low cost dialysis unveiled

      09/03/2016

    • New blood pressure target – the lower the better

      10/11/2015

    • Therapeutic Evaluation of STeroids in IgA Nephropathy Global study (TESTING)

    • India, China, Indonesia, Pakistan and Nigeria reveal shocking preventable death rates from gaps in kidney failure treatment – says latest global research

      15/03/2015

    • Fibrates reduce CV risk in patients with CKD

    最近的出版物

    • The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

    • Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

    • Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.

    • Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

    • Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial

    查看所有出版物

    Twitter Handle

    VladoPerkovic

    Link/s

    Research Gate

    • 关于我们
    • 我们的工作
    • 新闻与事记
    • 我们的成绩
    • 职业和学习
    • Get involved
    • 将思路转化为影响力
    • 联系我们
    • Donate

    The George Institute for Global Health

    308, Third Floor, Elegance Tower, Plot No. 8, Jasola District Centre
    New Delhi 110025 India
    Tel: +91 11 415 880 91-93
    Fax: +91 11 415 880 90
    info@georgeinstitute.org.in

    乔治研究院各国网站:

    • 乔治研究院各国网站:
    • 澳大利亚
    • 中国
    • 印度
    • 英国

    Social links India

    • Facebook
    • Twitter
    • YouTube

    订阅电子新闻简报

    Copyright © 2022 The George Institute

    Footer Links

    • Data sharing policy
    • Whistleblower policy
    • Modern slavery statement
    • Research code policy
    • PHS awards financial COI policy
    • Sitemap
    Please register to download the report
    ×

    Thank you for your interest in the FoodSwitch – State of the Food Supply Report 2021

    You should receive an email with a link to download the report.

    If you don't see it in your inbox, please check you spam folder in case it has been held there.